Detalhe da pesquisa
1.
Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention.
Annu Rev Immunol
; 38: 673-703, 2020 04 26.
Artigo
Inglês
| MEDLINE | ID: mdl-32340576
2.
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.
Cell
; 182(4): 812-827.e19, 2020 08 20.
Artigo
Inglês
| MEDLINE | ID: mdl-32697968
3.
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection.
Cell
; 174(4): 938-952.e13, 2018 08 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30096313
4.
Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G.
Cell
; 165(4): 813-26, 2016 May 05.
Artigo
Inglês
| MEDLINE | ID: mdl-27114034
5.
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody.
Cell
; 165(2): 449-63, 2016 Apr 07.
Artigo
Inglês
| MEDLINE | ID: mdl-26949186
6.
Structural diversity of the SARS-CoV-2 Omicron spike.
Mol Cell
; 82(11): 2050-2068.e6, 2022 06 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35447081
7.
Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies.
Cell
; 158(3): 481-91, 2014 Jul 31.
Artigo
Inglês
| MEDLINE | ID: mdl-25065977
8.
Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys.
Cell
; 155(3): 531-9, 2013 Oct 24.
Artigo
Inglês
| MEDLINE | ID: mdl-24243013
9.
Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials.
PLoS Pathog
; 19(6): e1011469, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37384759
10.
US National Institutes of Health Prioritization of SARS-CoV-2 Variants.
Emerg Infect Dis
; 29(5)2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37054986
11.
Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens.
PLoS Pathog
; 17(10): e1009807, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34679128
12.
Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primates.
PLoS Pathog
; 17(6): e1009624, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-34086838
13.
Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1.
N Engl J Med
; 388(7): 662-664, 2023 02 16.
Artigo
Inglês
| MEDLINE | ID: mdl-36652339
14.
Complete protection of the BALB/c and C57BL/6J mice against Ebola and Marburg virus lethal challenges by pan-filovirus T-cell epigraph vaccine.
PLoS Pathog
; 15(2): e1007564, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30817809
15.
Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies.
PLoS Pathog
; 15(9): e1008026, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31527908
16.
Correction: Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies.
PLoS Pathog
; 15(12): e1008200, 2019 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-31790514
17.
Polyvalent vaccine approaches to combat HIV-1 diversity.
Immunol Rev
; 275(1): 230-244, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28133800
18.
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination.
N Engl J Med
; 386(11): 1088-1091, 2022 03 17.
Artigo
Inglês
| MEDLINE | ID: mdl-35081298
19.
Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections.
PLoS Pathog
; 14(3): e1006860, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29505593
20.
Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV.
Nature
; 505(7484): 502-8, 2014 Jan 23.
Artigo
Inglês
| MEDLINE | ID: mdl-24352234